Ion Exchange India Ltd (IONEXCHANG) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Ion Exchange India Ltd on NSE and BSE, with an AI summary of each filing.
ION Exchange (India) Limited has informed the Exchange about the change in designation of Mr. Rajesh Sharma from Executive Chairman to Non- Executive Non-Independent Chairman of the Company ....
Change in Management · 04 Nov 2026, 3:41 am
Ion Exchange Approves Rajesh Sharma Transition to Non-Executive Chairman Ion Exchange (India) Limited announced that its Board of Directors approved the redesignation of Mr. Rajesh Sharma from Executive Chairman to Non-Executive Non-Independent Chairman, effective 1st Jan'27. Mr. Sharma, who joined the company in Jan'74 and served as Managing Director from 2000 to 2024, requested the transition to a non-executive role. The company will seek necessary shareholder approval for the redesignation via Postal Ballot in due course.
ION Exchange (India) Limited has submitted to the Exchange, the Unaudited Financial Results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026.
Financial Result · 04 Nov 2026, 3:33 am
ION Exchange (India) Limited has submitted to the Exchange, the Unaudited Financial Results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026.
Outcome · 04 Nov 2026, 3:28 am
ION Exchange (India) Limited has submitted to the Exchange, the unaudited financial results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026.
Outcome · 04 Nov 2026, 3:26 am
Ion Exchange India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 67,473 (-8.1% YoY | -3.7% QoQ) ■ EBITDA: -8,476 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -12.6 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: -8,105 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -6.84 (Profit to Loss YoY | Profit to Loss QoQ)
ION Exchange (India) Limited has informed the Exchange about the revised Intimation of Earnings Conference Call.
Intimation · 05 Nov 2026, 2:00 pm
Ion Exchange Reschedules Q2/H1-FY27 Earnings Conference Call to 5th Nov'26 Ion Exchange (India) Limited has revised the date for its Q2/H1-FY27 earnings conference call with investors and analysts to discuss financial performance for the period ended 30th Sep'26. The call is now scheduled for Thursday, 5th Nov'26, at 2:00 PM IST. Management will be represented by Vice Chairman Aankur Patni, MD & CEO Indraneel Dutt, Group CFO Vasant Naik, and Company Secretary Nikisha Solanki. Universal dial-in numbers include +91 22 6280 1341 and +91 22 7115 8242.
ION EXCHANGE (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
ION Exchange (India) Limited has informed the Exchange about the Schedule of Earnings Conference Call.
Intimation · 29 Oct 2026, 12:02 am
Ion Exchange (India) Limited Schedules Q2/H1 FY27 Earnings Conference Call Ion Exchange (India) Limited will host an earnings conference call on 5th Nov'26 at 2:00 PM IST to discuss its financial performance for Q2 and H1 ended 30th Sep'26. Senior management, including Vice Chairman Aankur Patni, MD & CEO Indraneel Dutt, and Group CFO Vasant Naik, will represent the company. Universal access dial-in numbers are +91 22 6280 1341 and +91 22 7115 8242, alongside international toll-free options for the USA, UK, Singapore, and Hong Kong.
Ion Exchange India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Intimation · 03 Nov 2026, 5:30 am
Ion Exchange (India) Schedules Board Meeting to Approve Q2 Results Ion Exchange (India) Limited has informed stock exchanges that its Board of Directors is scheduled to meet on 3rd Nov'26. The board will, inter alia, consider and approve the unaudited financial results of the company for the second quarter and half-year ended 30th Sep'26.
To consider and approve the Unaudited financial results for the second quarter and half year ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
ION Exchange (India) Limited has informed the Exchange regarding submission of Trust Deed of 'Ion Exchange ESOP Trust'
Others (Uncategorized) · 09 Oct 2026, 11:40 pm
Ion Exchange Submits Registered ESOP Trust Deed to Exchanges Ion Exchange (India) Limited submitted the registered Trust Deed of "Ion Exchange ESOP Trust" to stock exchanges pursuant to SEBI (SBEB and Sweat Equity) Regulations, 2021. The irrevocable employee welfare trust, executed on 23rd Jul'26 with an initial corpus of Rs 10,000, was established to administer and implement the Ion Exchange (India) Limited – Employees Stock Option Scheme, 2026. Qapita EquityTech Limited has been appointed as the corporate trustee to facilitate secondary share acquisitions and option administration for eligible employees.
Voting Results and Scrutinizers Report for the 62nd Annual General Meeting held on September 11, 2026
Annual General Meeting · 11 Sept 2026, 11:53 pm
Proceedings of 62nd Annual General Meeting held on September 11, 2026
Annual General Meeting · 11 Sept 2026, 11:47 pm
Please find enclosed a letter being sent to those shareholders who have not registered their email address(es) with the Company, its Registrar and Share Transfer Agent, or their respective ....
Annual General Meeting · 18 Aug 2026, 11:02 pm
Please find enclosed herewith the Annual Report for the financial year 2025-26.
Others (Uncategorized) · 18 Aug 2026, 10:50 pm
Please find enclosed herewith the BRSR for the financial year 2025-26.
Others (Uncategorized) · 18 Aug 2026, 10:38 pm
Ion Exchange: FY26 Business Responsibility and Sustainability Report Highlights Ion Exchange released its Business Responsibility and Sustainability Report for FY26 on 18 Aug'26. The report, filed on a standalone basis, shows revenue segmentation of Engineering (60%), Chemical (25%), and Consumer Products (15%), with exports contributing 21% to total turnover. FY26 permanent employee turnover increased to 30.99% from 17.41% in FY25. The company targets carbon neutrality by 2030 and net-zero GHG emissions by 2050. Total GHG emissions rose to 17,263 tCO2e. It reported zero fatalities and a Lost Time Injury Frequency Rate of 0.
Please find enclosed herewith the Notice of 62nd Annual General Meeting to be held on Friday, September 11, 2026.
Annual General Meeting · 18 Aug 2026, 10:35 pm
ION Exchange (India) Limited has informed the Exchange about Transcript of the Conference Call held on Monday, August 10, 2026
Transcript · 18 Aug 2026, 3:52 am
ION Exchange (India) Limited has informed the Exchange about Link of Recording of Earnings Conference Call for Q1 - F.Y. 2026-27
Audio / Video · 11 Aug 2026, 12:26 am
Ion Exchange Publishes Q1 FY27 Earnings Call Audio Recording Ion Exchange (India) Ltd. has submitted the audio recording of its earnings conference call held on 10 Aug'26. The call covered the company's operational and financial performance for the first quarter ended 30 Jun'26 (Q1 FY27). The recording is now available on the company's website for investors and analysts, as per SEBI disclosure requirements. This provides access to management's discussion and outlook following the release of the quarterly results.
Please find attached revised Investor Presentation.
Investor Presentation · 11 Aug 2026, 12:17 am
Ion Exchange Outlines Strategic Capex and New Segment Reporting Ion Exchange details strategic investments to scale capacity and market share. Pharma Resins capacity will see a 5X expansion, targeting a 7.5% global share. Industrial Resins capacity will double, aiming for a 5% share. Membrane manufacturing at Goa is also expanding, with a strategic partnership with Mann+Hummel set for 2026. The company is transitioning to five new reporting segments: Treatment Solutions, Industrial Products, Lifecycle Services, Specialty Chemicals, and Consumer Products, providing greater business clarity and replacing the previous three-segment structure.
Please find enclosed the Earnings Presentation for the first quarter ended June 30, 2026
Investor Presentation · 10 Aug 2026, 6:44 pm
Ion Exchange Q1 FY27: Revenue Rises but Margin Pressure Hits Profitability Ion Exchange reported a 20.1% YoY rise in Q1 FY27 consolidated operating income to INR 7,005 Mn, driven by strong growth across all segments. However, Operating EBITDA fell 49.3% YoY to INR 318 Mn, with margins contracting 622 bps to 4.54% due to legacy project costs and geopolitical impacts. Consequently, Profit After Tax declined 93.6% YoY to INR 31 Mn. The total order book stood at INR 24,730 Mn with a robust bid pipeline of INR 97,770 Mn as of Jun'26.
Please find attached the Investor Presentation.
Investor Presentation · 10 Aug 2026, 6:21 pm
Ion Exchange Unveils New Segments and Capacity Expansion Plans Ion Exchange has introduced a new reporting structure, shifting from three segments to five: Treatment Solutions, Industrial Products, Lifecycle Services, Specialty Chemicals, and Consumer Products. The company highlights significant capacity expansions, including a 5X increase for industrial resins at Roha, aiming to lift global market share from 2.5% to 10%. Additionally, pharma resins capacity at Ankleshwar will expand 6X, targeting a market share increase from 3.5% to 17%. Strategic investments also focus on expanding membrane manufacturing and standard systems capabilities.
Please find attached the Investor Presentation.
Investor Presentation · 10 Aug 2026, 6:12 pm
Ion Exchange Highlights Capacity Expansion and New Reporting Structure Ion Exchange detailed strategic investments in its Aug'26 investor presentation. Key initiatives include a 5x capacity expansion for industrial resins at Roha, increasing global market share from 2.5% to 10%. Pharma resin capacity at Ankleshwar will grow 6x, targeting a 17% market share. The company also introduced a new reporting structure with five segments: Treatment Solutions, Industrial Products, Lifecycle Services, Specialty Chemicals, and Consumer Products. The Treatment Solutions segment is the largest, with FY26 revenue of ₹1,122 Cr, though its EBIT has declined.
ION Exchange (India) Limited has informed the Exchange about the Schedule of Special Call on Reclassification of Reporting Segments and Earnings Conference Call.
Intimation · 10 Aug 2026, 3:00 pm
Ion Exchange Schedules Investor Call for Q1 FY27 Results and Segment Reclassification Ion Exchange (India) Ltd. will host an investor and analyst call on 10 Aug'26. A special call at 2:00 PM will address the reclassification of reporting segments. This will be followed by the Q1 FY27 earnings conference call at 3:00 PM to discuss financial performance for the quarter ended 30 Jun'26. Management representation will include the Vice Chairman, MD & CEO, and Group CFO. This event is crucial for understanding the company's new reporting structure and its impact on financial analysis.
ION Exchange (India) Limited has submitted to the Exchange, the Unaudited Financial Results (Standalone & Consolidated) for the first quarter ended June 30, 2026.
Financial Result · 06 Aug 2026, 1:49 am
Ion Exchange Q1 FY27 Standalone PAT Declines 76% YoY Ion Exchange reported Q1 FY27 standalone results with revenue from operations at INR 63,556 lacs, a 22.7% YoY increase. However, a significant rise in total expenses to INR 63,343 lacs, up 33.5% YoY, led to a sharp contraction in margins. Profit after tax (PAT) fell 75.7% YoY to INR 1,140 lacs for the quarter ended 30 Jun'26, compared to INR 4,688 lacs in Q1 FY26. Consequently, basic EPS dropped to INR 0.927 from INR 3.814 in the prior year period.
ION Exchange (India) Limited has submitted to the Exchange, the unaudited financial results (Standalone & Consolidated) for the first quarter ended June 30, 2026.
Outcome · 06 Aug 2026, 1:42 am
Ion Exchange India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 70,046 (+20.1% YoY | -18.9% QoQ) ■ EBITDA: 3,174 (-49.2% YoY | +59.7% QoQ) ■ EBITDA Margin (%): 4.5 (-619 bps YoY | +223 bps QoQ) ■ PAT: 411 (-91.6% YoY | -83.0% QoQ) ■ EPS (INR): 0.35 (-91.6% YoY | -83.0% QoQ) Ion Exchange India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) Segmental Performance Treatment Solutions ■ Revenue: 20,988 (+14.1% YoY | -42.6% QoQ) ■ EBIT: -1,735 (Profit to Loss YoY | -1358.0% QoQ) ■ EBIT Margin (%): -8.3 (Profit to Loss YoY | -794 bps QoQ) Industrial Products ■ Revenue: 10,513 (+14.0% YoY | -21.6% QoQ) ■ EBIT: 1,248 (+146.6% YoY | +1.0% QoQ) ■ EBIT Margin (%): 11.9 (+638 bps YoY | +266 bps QoQ) Lifecycle Services ■ Revenue: 7,155 (+28.0% YoY | -23.7% QoQ) ■ EBIT: 713 (+21.7% YoY | -43.6% QoQ) ■ EBIT Margin (%): 10.0 (-52 bps YoY | -351 bps QoQ) Specialty Chemicals ■ Revenue: 22,965 (+21.6% YoY | +0.0% QoQ) ■ EBIT: 2,227 (-51.8% YoY | -27.9% QoQ) ■ EBIT Margin (%): 9.7 (-1479 bps YoY | -374 bps QoQ) Consumer Products ■ Revenue: 11,236 (+33.3% YoY | +21.0% QoQ) ■ EBIT: -34.0 (+24.4% YoY | +92.3% QoQ) ■ EBIT Margin (%): -0.3 (+23 bps YoY | +443 bps QoQ)